Use of sodium-glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020.

Author(s)
Hare, Matthew
Chen, Winnie
Berhane, Thomas
Corpus, Sumaria
Maple-Brown, Louise
Publication Date
2025-02-24
Abstract
Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.
Affiliation
Endocrinology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Wellbeing and Chronic Preventable Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Wellbeing and Chronic Preventable Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Danila Dilba Health Service, Darwin, Northern Territory, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Endocrinology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Aboriginal & Torres Strait Islander Advisory Group, Diabetes across the Lifecourse: Northern Australia Partnership, Menzies School of Health Research, Darwin, Northern Territory, Australia.
Endocrinology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Wellbeing and Chronic Preventable Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Citation
Intern Med J . 2025 Feb 24. doi: 10.1111/imj.16653. Online ahead of print.
ISSN
1445-5994
OrcId
0000-0002-9364-3368
0000-0002-3473-3080
Pubmed ID
https://pubmed.ncbi.nlm.nih.gov/39989248/?otool=iaurydwlib
Link
Subject
general practice
indigenous health
pharmacoepidemiology
primary care
rural health service
type 2 diabetes
Title
Use of sodium-glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020.
Type of document
Journal Article
Entity Type
Publication

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/fe03fb71-bcef-4f4b-9502-f2adedfd5085